Ophthalmology Times

Throwback Series: Managing bilateral diabetic macular edema early in practice

David Eichenbaum, MD, FASRS, recalls an early-career case managing bilateral diabetic macular edema with frequent ...
Healio

First patient dosed in study of dual inflammasome inhibitor for diabetic macular edema

Please provide your email address to receive an email when new articles are posted on . K8 inhibits NLRP3 and NLRP4, inflammasomes believed to be responsible for diabetic macular edema disease ...
Nasdaq

ScPharma: FDA Approves FUROSCIX For Treating Edema In Chronic Kidney Disease Patients

(RTTNews) - scPharmaceuticals Inc. (SCPH) announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for FUROSCIX to expand the indication to ...
Fierce Biotech

Roche claws its way toward FDA as phase 3 eye disease trials yield mixed results

Roche believes it has exited phase 3 with data to support talks with regulatory agencies, but the mixed results raise ...